Seqens adds to US R&D lab
Submitted by:
Andrew Warmington
CDMO and API manufacturer Seqens has announced a “multi-million dollar” investment in its R&D laboratory
Solvay to split in two?
Submitted by:
Andrew Warmington
Following on from the examples of other major chemicals companies, such as Bayer and DuPont
New site for Flamma
Submitted by:
Andrew Warmington
CDMO Flamma has acquired a third API manufacturing facility in Italy from Teva. The Sicor
Bayer sells Environmental Science Professional business
Submitted by:
Andrew Warmington
Private equity firm Cinven has agreed to acquire Bayer’s Environmental Science Professional (ESP) business for
LanzaTech plans Nasdaq launch
Submitted by:
Andrew Warmington
Chicago-based carbon capture and transformation (CCT) firm LanzaTech has announced plans to launch on the
Lonza completes HPAPI expansion
Submitted by:
Andrew Warmington
Lonza has completed an expansion at its API manufacturing site at Nansha, China, as part
QPhos available from Sinocompound
Submitted by:
Andrew Warmington
Sinocompound Catalysts, a supplier of advanced homogeneous catalysts and ligands based in Zhangjiagang, China, has
Sterling buys Novartis site in Ireland
Submitted by:
Andrew Warmington
CDMO Sterling Pharma Solutions has agreed to acquire Novartis’s 45-hectare Ringaskiddy campus near Cork, Ireland
New CEO at Hovione
Submitted by:
Andrew Warmington
The board and shareholders of Hovione have named Dr Jean-Luc Herbeaux (right) as
New BASF alkylethanolamines plant
Submitted by:
Andrew Warmington
BASF is building a new world-scale plant for alkylethanolamines at the verbund site in Antwerp